Creative Biolabs Developed Antibody Modification and Conjugation for Research Use

Share this news:

Creative Biolabs has developed various strategies for antibody modification and conjugation in antibody-drug conjugate (ADC) development.

-- With advanced equipments, techniques and antibody platforms, scientists and technicians from Creative Biolabs can perform custom-designed conjugate antibodies to meet specific requirements from the market.

Recent years, ADC has received much attention in the therapy of various diseases. Owing to the specificity of the monoclonal antibody moiety and the cytotoxicity of the payloads, it performs as targeted therapy.

“According to the different reactive sites”, said Professor Monika, scientific officer of Creative Biolabs, “the conjugation strategies can be classified into non-specific conjugation through native residues, site-specific conjugation through genetically engineered sites and UV cross-linking.

Non-specific Conjugation Technologies

Non-specific conjugation technologies are based on the principle of utilizing reactive side chains of naturally occurring amino acids, such as lysine and cysteine. This method is facile and performed by altering the electrostatic properties (isolectric points) and hydrophobicity of the parent antibodies.

Site-specific Conjugation

Site-specific conjugation can increase the site specificity of ADC conjugation by altering amino acid sequences to introduce reactive handles, which includes thio-engineered antibodies (THIOMAB) and enzymatic modified antibodies.

UV Cross-linking

UV cross-linking is also a site-specific conjugation but does not require genetic engineering or pre-activated scaffolds. It is suitable to the payloads featuring a UV reactive indole-3-butyric acid (IBA) moiety. Moreover, a two-step conjugation strategy of UV photocrosslinking is now developed to facilitate more molecules conjugate to the antibody.

Creative Biolabs utilizes various strategies for antibody modification and conjugation, such as cysteine-based conjugation, unnatural amino acids-based conjugation and enzymatic modified antibody.

About Creative Biolabs

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early antibody drug discovery and development.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
Phone: 1-516-669-8109

Release ID: 138896

CONTACT ISSUER
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
SUBSCRIBE FOR MORE